Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00354770 · ClinicalTrials.gov registry record · Phase 2
N-Acetyl Cysteine in Trichotillomania
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00354770: Completed Phase 2 study, sponsored by University of Chicago.
NCT00354770 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00354770, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a 12-week, double-blind study of N-Acetyl Cysteine in the treatment of trichotillomania
Primary Outcome
There is no minimum or maximum score to quantify 'good' or 'poor' improvement based on this scale. The total score can range from 0-28 with zero being no problems to 28 being the most severe score one can receive.A total of 6 assessments were made, however only the final score (the score at the final visit after 12 weeks) was reported here to show the final outcome measure that was used in the final report of possible improvement and what was reported for final publication of data.
Interventions
- DRUG Placebo
- DRUG N-Acetyl Cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
What the finished NCT00354770 record still lists
NCT00354770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00354770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00354770 about?
NCT00354770 is a clinical study titled "N-Acetyl Cysteine in Trichotillomania". This is a 12-week, double-blind study of N-Acetyl Cysteine in the treatment of trichotillomania
What is the current status of trial NCT00354770?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2006-07. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00354770?
The interventions under investigation include: Placebo (DRUG), N-Acetyl Cysteine (DRUG).
Who is sponsoring clinical trial NCT00354770?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00354770's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia